TY - GEN 
AU - Espinosa-Jovel C
AU - Valencia N
AU - Gaitán L
AU - Riveros S.
PY - 2024
SN - 21991154
UR - http://hdl.handle.net/10818/61897
AB - Background: Third-generation antiseizure medications, such as brivaracetam, are recognized for their superior safety, tolerability, and pharmacokinetic profiles. However, their potential benefits are often limited in low-income populations because of...
LA - eng
PB - Drugs - Real World Outcomes
KW - Brivaracetam
KW - Cannabidiol
KW - Carbamazepine
KW - Clobazam
KW - Clonazepam
KW - Lacosamide
KW - Lamotrigine
TI - Impact of Third-Generation Antiseizure Medications on People with Epilepsy in a Low-Income Population: The Brivaracetam Experience in a Real-World Study
DO - 10.1007/s40801-024-00445-y
ER -